Jessica Madigan, B.Sc. (chemistry, 2008), has 14+ years of experience focused on nucleic acid manufacturing and development. Jessica played a key role at start-up company TriLink BioTechnologies (first CMO/CDMO for mRNA and inventors of CleanCap technology), leading to successful launch of mRNA, plasmid, capping analogs, and modified nucleotide products. Jessica also holds a Project Management Professional (PMP) Certification and successfully managed over 30 API manufacturing projects for mRNA early-phase clinical trials. At BIOVECTRA (2022–present), Jessica supports business development efforts for pDNA, mRNA, and formulation services.